Preconditioning cultured human pediatric myocytes requires adenosine and protein kinase C

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 272, Issue 3 41-3, 1997, Pages

  Ikonomidis, John S ^a   Shirai, Toshizumi ^a   Weisel, Richard D ^a,b   Derylo, Bogdan ^a   Rao, Vivek ^a   Whiteside, Catherine I ^a   Mickle, Donald A G ^a   Li, Ren Ke ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

cardiomyocytes; cell viability; signal transduction

Indexed keywords

8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CALPHOSTIN; PHENYLISOPROPYLADENOSINE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FALLOT TETRALOGY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030984979     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.272.3.h1220     Document Type: Article

References (66)

1. Alexander, D. R., J. D. Graves, S. C. Lucas, D. A. Cantrell, and N. J. Crumpton. A method for measuring protein kinase C activity in permeabilized T lymphocytes by using peptide substrates. Biochem. J. 268: 303-308, 1990.
2. Armstrong, S. C., J. M. Downey, and C. E. Ganote. Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. Cardiovasc. Res. 28: 72-77, 1994.
3. 3 receptor involvement. Cardiovasc. Res. 28: 1049-1056, 1994.
4. Armstrong, S. C., and C. E. Ganote. Preconditioning of isolated rabbit cardiomyocytes: effects of glycolytic blockade, phorbol esters, and ischaemia. Cardiovasc. Res. 28: 1700-1706, 1994.
5. Belardinelli, L., J. Linden, and R. Berne. The cardiac effects of adenosine. Prog. Cardiovasc. Dis. 32: 73-97, 1989.
6. Bell, R. M., and D. J. Burns. Lipid activation of protein kinase C. J. Biol. Chem. 266: 4661-4664, 1991.
7. Bogoyevitch, M. A., P. J. Parker, and P. H. Sugden. Characterization of protein kinase C isotype expression in adult rat heart. Protein kinase C-ε is a major isotype present and it is activated by phorbol esters, epinephrine, and endothelin. Circ. Res. 72: 757-767, 1993.
8. Brooks, G., R. Walsh, and J. M. Downey. Phosphorylation of 80K/MARCKS, a specific substrate of protein kinase C, occurs after 5′ of ischemia but only in preconditioned hearts (Abstract). Circulation 88, Suppl. II: I-191, 1993.
9. Bruns, R. F., F. D. Miller, R. L. Merriman, J. J. Howbert, W. F. Heath, E. Kobayashi, I. Takahashi, T. Tamaoki, and H. Nakano. Inhibition of protein kinase C by calphostin C is light-dependent. Biochem. Biophys. Res. Commun. 176: 288-293, 1991.
10. Cowan, D. B., R. D. Weisel, W. G. Williams, and D. A. G. Mickle. The regulation of glutathione peroxidase gene expression by oxygen tension in cultured human cardiomyocytes. J. Mol. Cell. Cardiol. 24: 423-433, 1992.
11. Cowan, D. B., R. D. Weisel, W. G. Williams, and D. A. G. Mickle. Identification of oxygen responsive elements in the 5′-flanking region of the human glutathione peroxidase gene. J. Biol. Chem. 268: 26904-26910, 1993.
12. Davis, R. J., and M. P. Czech. Tumor promoting phorbol esters cause the phosphorylation of epidermal growth factor receptors in normal human fibroblasts at threonine-654. Proc. Natl. Acad. Sci. USA 82: 1974-1978, 1985.
13. Delehanty, J. M., Y. Himura, H. Elam, W. B. Hood, Jr., and C.-S. Liang. β-Adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE content. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H930-H935, 1994.
14. Fantini, E., P. Athias, M. Courtois, S. Khatami, A. Grynberg, and A. Chevalier. Oxygen and substrate deprivation in isolated rat cardiac myocytes: temporal relationship between electromechanical and biochemical consequences. Can. J. Physiol. Pharmacol. 68: 1148-1156, 1990.
15. Freshney, R. I. Culture of Animal Cells: A Manual of Basic Technique. New York: Liss, 1983, p. 129-143.
16. Heasley, L. E., and G. L. Johnson. Regulation of protein kinase C by nerve growth factor, epidermal growth factor, and phorbol esters in PC12 pheochromocytoma cells. J. Biol. Chem. 264: 8646-8652, 1989.
17. Heasley, L. E., and G. L. Johnson. Detection of nerve growth factor and epidermal growth factor-regulated protein kinases in PC12 cells with synthetic peptide substrates. Mol. Pharmacol. 35: 331-338, 1989.
18. Herbert, J. M., J. M. Augereau, and J. P. Maffrand. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172: 993-999, 1990.
19. Hug, H., and T. F. Sarre. Protein kinase C isoenzymes: divergence in signal transaction? Biochem. J. 291: 329-343, 1993.
20. Hull-Ryde, E. A., W. R. Lewis, C. D. Veronee, and J. E. Lowe. Simple step gradient elution of the major high-energy compounds and their metabolites in cardiac muscle using high-performance liquid chromatography. J. Chromatogr. 377: 165-174, 1977.
21. Ikonomidis, J. S., L. C. Tumiati, R. D. Weisel, D. A. G. Mickle, and R.-K. Li. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischemia. Cardiovasc. Res. 28: 1285-1291, 1994.
22. Kitakaze, M., T. Minamino, Y. Shinozaki, H. Sakamoto, H. Mori, T. Kurihara, and M. Hori. Activation of protein kinase C and subsequent activation of ectosolic 5′-nucleotidase as a major cause for the infarct size limiting effect of ischemic preconditioning (Abstract). Circulation 90, Suppl. I: I-207, 1994.
23. Kloner, R. A., and D. M. Yellon. Does ischemic preconditioning occur in patients? J. Am. Coll. Cardiol. 24: 1133-1142, 1994.
24. Kobayashi, E., H. Nakano, M. Morimoto, and T. Tamaoki. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159: 548-553, 1989.
25. 6-phenylisopropyladenosine on myocardial inositol phosphate content and force of contraction. Br. J. Pharmacol. 101: 829-834, 1990.
26. Kohout, T. A., and T. R. Rogers. Use of a PCR-based method to characterize protein kinase C isoform expression in cardiac cells. Am. J. Physiol. 264 (Cell Physiol. 33): C1350-C1359, 1993.
27. Kolocassides, K. G., and M. Galinanes. The specific protein kinase C inhibitor chelerythrine fails to inhibit preconditioning in the rat heart (Abstract). Circulation 90: I-208, 1994.
28. Lasley, R. D., G. M. Anderson, and R. M. Mentzer. Ischaemic and hypoxic preconditioning enhance postischemic recovery of function in the rat heart. Cardiovasc. Res. 27: 565-570, 1993.
29. Lawson, C. S. Does ischemic preconditioning occur in the human heart? Cardiovasc. Res. 28: 1461-1466, 1994.
30. Lee, H. T., C. I. Thompson, A. Hernandez, J. L. Lewy, and F. L. Belloni. Cardiac desensitization to adenosine analogues after prolonged R-PIA infusion in vivo. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H1916-H1927, 1993.
31. Li, R.-K., D. A. G. Mickle, R. D. Weisel, S. C. Carson, S. A. Omar, L. C. Tumiati, G. J. Wilson, and W. G. Williams. Human pediatric and adult ventricular cardiomyocytes in culture; assessment of phenotypic changes with passaging. Cardiovasc. Res. 32: 362-373, 1996.
32. Li, R.-K., N. Shaikh, R. D. Weisel, W. G. Williams, and D. A. G. Mickle. Oxyradical-induced antioxidant and lipid changes in cultured human cardiomyocytes. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H2204-H2211, 1994.
33. Li, R.-K., R. D. Weisel, W. G. Williams, and D. A. G. Mickle. Method of culturing cardiomyocytes from human pediatric ventricular myocardium. J. Tissue Cult. Methods 14: 93-100, 1992.
34. 2b receptors in cultured fetal chick heart cells. High- and low-affinity coupling to stimulation of myocyte contractility and cAMP accumulation. Circ. Res. 76: 242-251, 1995.
35. Limas, C. J., and C. Limas. Involvement of microtubules in the isoproterenol-induced 'down'-regulation of myocardial β-adrenergic receptors. Biochim. Biophys. Acta 735: 181-184, 1983.
36. ATP channels in rabbit ventricular cardiomyocytes (Abstract). Circulation 90, Suppl. I: I-478, 1994.
37. 3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc. Res. 28: 1057-1061, 1994.
38. 1 adenosine receptors in rabbit heart. Circulation 84: 350-356, 1991.
39. Liu, Y., K. Ytrehus, and J. M. Downey. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J. Mol. Cell. Cardiol. 26: 661-668, 1994.
40. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
41. Matsuyama, T., H. Sato, A. Kitabatake, H. Ozaki, K. Imai, Y. Ishida, M. Hori, M. Inoue, and T. Kamada. Blunted cardiac response to exercise-induced sympathetic stimulation in non-failing aortic regurgitation; insight into role of cardiac dilation in hyporesponse of failing hearts. Jpn. Circ. J. 56: 117-127, 1992.
42. Merchant, D. J., R. H. Kahn, and W. H. Murphy. Handbook of Cell and Organ Culture. Minneapolis, MN: Burgess, 1964, p. 157.
43. Mickle, D. A. G., R.-K. Li, R. D. Weisel, L. C. Tumiati, and T. W. Wu. Water soluble antioxidant specificity against free radical injury using cultured human ventricular myocytes and fibroblasts and saphenous vein endothelial cells. J. Mol. Cell. Cardiol. 22: 1297-1304, 1990.
44. Mitchell, M. B., X. Meng, L. Ao, J. M. Brown, A. H. Harken, and A. Bannerjee. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ. Res. 76: 73-81, 1995.
45. Mochly-Rosen, D., H. Khaner, J. Lopez, and B. L. Smith. Intracellular receptor for activated protein kinase C. Identification of a binding site for the enzyme. J. Biol. Chem. 266: 14866-14868, 1991.
46. Moses, R. L., and W. C. Claycomb. Differential membrane specializations and myofibrillar breakdown and recovery in cultured adult cardiac myocytes treated with PMA and diacylglycerol. J. Cell. Sci. 93: 93-105, 1989.
47. Murry, C. E., V. J. Richard, K. A. Reimer, and R. B. Jennings. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ. Res. 66: 913-931, 1990.
48. Murti, K. G., K. Kaur, and R. M. Goorha. Protein kinase C associates with intermediate filaments and stress fibers. Exp. Cell. Res. 202: 36-44, 1992.
49. Musser, B., M. E. Morgan, M. Leid, T. F. Murray, J. Linden, and R. E. Vestal. Species comparison of adenosine and β-adrenoceptors in mammalian atrial and ventricular myocardium. Eur. J. Pharmacol. 246: 105-111, 1993.
50. Nishizuka, Y. Studies and perspectives of protein kinase C. Science 233: 305-312, 1986.
51. Nishizuka, Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614, 1992.
52. Przyklenk, K., B. Bauer, M. Ovize, R. A. Kloner, and P. Whittaker. Regional ischemic "preconditioning" protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87: 893-899, 1993.
53. Rasmussen, H., R. A. Calle, S. Ganesan, J. I. Smallwood, D. C. Throckmorton, and W. S. Zawalich. Protein kinase C: role in sustained cellular responses. In: Protein Kinase C. Current Concepts and Future Perspectives, edited by D. S. Lester and R. M. Epand. London: Ellis Horwood, 1992, p. 183-236.
54. Schwibert, E., H. Karlson, P. Friedman, P. Dietl, and W. Speilman. Adenosine regulates a chloride channel via protein kinase C and a G protein in a rabbit cortical collecting duct cell line. J. Clin. Invest. 89: 834-841, 1992.
55. Shizukuda, Y., T. Iwamoto, R. T. Mallet, and H. F. Downey. Hypoxic preconditioning attenuates stunning caused by repeated coronary artery occlusions in dog heart. Cardiovasc. Res. 27: 559-564, 1993.
56. Simkhovich, B. Z., R. A. Kloner, and K. Przyklenk. Brief preconditioning ischemia does not trigger translocation of protein kinase C in canine myocardium (Abstract). Circulation 90: I-208, 1994.
57. Speechly-Dick, M. E., M. M. Mocanu, and D. M. Yellon. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ. Res. 75: 586-590, 1994.
58. 1 receptor in a cell line (28A) derived from rabbit collecting tubule. Am. J. Physiol. 263 (Cell Physiol. 32): C502-C508, 1992.
59. Tumiati, L. C., R.-K. Li, R. D. Weisel, W. G. Williams, and D. A. G. Mickle. An in vitro model to study myocardial ischemic injury. J. Tissue Cult. Methods 16: 1-9, 1994.
60. Vemuri, R., S. Yagev, M. Heller, and A. Pinson. Studies on oxygen and volume restrictions in cultured cardiac cells. I. A model for ischemia and anoxia with a new approach. In Vitro 21: 521-525, 1985.
61. Vogt, A., M. Barancik, D. Weihrauch, M. Arras, T. Podzuweit, and W. Schaper. Protection of ischemic porcine myocardium from infarction by an Ai-receptor agonist is not mediated by protein kinase C (Abstract). Circulation 90: I-371, 1994.
62. Walker, D. M., M. S. Marber, J. M. Walker, and D. M. Yellon. Preconditioning in isolated superfused rabbit papillary muscles. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1534-H1540, 1994.
63. White, T. E., J. M. Dickenson, S. P. Alexander, and S. J. Hill. Adenosine A1-receptor stimulation of inositol phospholipid hydrolysis and calcium mobilisation in DDT1 MF-2 cells. Br. J. Pharmacol. 106: 215-221, 1992.
64. Williams, B., and R. W. Schrier. Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes 41: 1464-1472, 1992.
65. Wolff, C., and G. H. Cook. Activation of steroidogenesis and adenylate cyclase in adrenal and Leydig tumor cells. J. Biol. Chem. 252: 687-693, 1977.
66. Ytrehus, K., Y. Liu, and J. M. Downey. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1145-H1152, 1994.